Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(3 sites)
United States
Orthopaedics NorthEast, Fort Wayne, Indiana Australia
Newcastle Private Hospital, Newcastle, New South Wales Macquarie University, Sydney, New South Wales